Williams, J. G., Alam, M. F., Alrubaiy, L., Arnott, I., Clement, C., Cohen, D., . . . Watkins, A. (2016). Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): A mixed methods, open-label, pragmatic randomised trial. Lancet Gastroenterol Hepatol.
Citação norma ChicagoWilliams, John G., et al. "Infliximab Versus Ciclosporin for Steroid-resistant Acute Severe Ulcerative Colitis (CONSTRUCT): A Mixed Methods, Open-label, Pragmatic Randomised Trial." Lancet Gastroenterol Hepatol 2016.
Citação norma MLAWilliams, John G., et al. "Infliximab Versus Ciclosporin for Steroid-resistant Acute Severe Ulcerative Colitis (CONSTRUCT): A Mixed Methods, Open-label, Pragmatic Randomised Trial." Lancet Gastroenterol Hepatol 2016.